Saroglitazar Cuts Blood Sugar More Than Dapagliflozin in Fatty Liver Study
A 25-week Indian cohort study found both saroglitazar and dapagliflozin improved liver fat and metabolic markers in MASLD patients, with ...
A 25-week Indian cohort study found both saroglitazar and dapagliflozin improved liver fat and metabolic markers in MASLD patients, with ...
A Spanish pilot randomized controlled trial found no significant 12-month HbA1c difference between online and face-to-face delivery of the same ...
A Bayesian network meta-analysis of 19 randomized trials finds combined mesenchymal stem/stromal cell plus mononuclear cell therapy lowered HbA1c and ...
A phase III trial in India found that a single-tablet combination of dapagliflozin, glimepiride, and metformin significantly outperformed co-administered glimepiride ...
A systematic review of nine randomized controlled trials in 383 obese individuals with diabetes found that aerobic and resistance training ...
A nationwide Chinese cohort study found that a composite index of remnant cholesterol and HbA1c was associated with increased stroke ...
A retrospective study of 1925 Japanese patients with type 2 diabetes found biguanides lowered HbA1c more than SGLT2 inhibitors, while ...
A 24-week controlled study found that a standardized eight-plant botanical formulation significantly reduced HbA1c, insulin resistance and inflammation in adults ...
A pragmatic cluster randomized trial will randomize 12 Midwest community health centers to a structured diabetes distress screening and intervention ...
An internet hospital platform service for discharged patients was linked to faster blood glucose decline and better arm recovery after ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine